Structures by: Ostapenko G. I.
Total: 13
<i>N</i>-[(4-Phenylthiazol-2-yl)carbamothioyl]benzamide
C17H13N3OS2
Acta Crystallographica Section E (2016) 72, 9 1343-1347
a=12.901(3)Å b=5.5160(11)Å c=23.143(5)Å
α=90° β=105.32(3)° γ=90°
<i>N</i>-{[4-(4-Bromophenyl)thiazol-2-yl]carbamothioyl}benzamide
C17H12BrN3OS2
Acta Crystallographica Section E (2016) 72, 9 1343-1347
a=37.210(7)Å b=4.0000(8)Å c=28.450(6)Å
α=90° β=128.69(3)° γ=90°
Ethyl {2-[4-(4-isopropylphenyl)thiazol-2-yl]phenyl}carbamate
C21H22N2O2S
Acta Crystallographica Section E (2016) 72, 9 1321-1325
a=5.4534(11)Å b=17.203(3)Å c=20.060(4)Å
α=90° β=90° γ=90°
Ethyl {2-[4-(3-nitrophenyl)thiazol-2-yl]phenyl}carbamate
C18H15N3O4S
Acta Crystallographica Section E (2016) 72, 9 1321-1325
a=23.840(5)Å b=9.7401(19)Å c=7.1403(14)Å
α=90° β=90° γ=90°
2-Phenyl-5,6,7,8-tetrahydroimidazo[2,1-<i>b</i>][1,3]benzothiazole
C15H14N2S
Acta Crystallographica Section E (2014) 70, 6 o668
a=12.523(3)Å b=10.699(3)Å c=18.930(5)Å
α=90.00° β=102.291(6)° γ=90.00°
2-(Adamantan-1-yl)-<i>N</i>-(6-methoxy-1,3-benzothiazol-2-yl)acetamide
C20H24N2O2S
Acta Crystallographica Section E (2013) 69, 9 o1472
a=11.0114(13)Å b=13.6647(18)Å c=13.9230(18)Å
α=61.554(3)° β=80.252(3)° γ=89.782(4)°
6-(4-Chlorophenyl)-3-methylimidazo[2,1-<i>b</i>]thiazole
C12H9ClN2S
Acta Crystallographica Section E (2013) 69, 11 o1701
a=7.0624(5)Å b=7.7132(5)Å c=10.3460(7)Å
α=93.3530(10)° β=90.1070(10)° γ=98.8320(10)°
2-Bromo-4-phenyl-1,3-thiazole
C9H6BrNS
Acta Crystallographica Section E (2014) 70, 2 o139
a=5.8934(3)Å b=10.6591(6)Å c=13.8697(7)Å
α=90.00° β=90.8120(10)° γ=90.00°
7-Nitro-2-phenylimidazo[2,1-<i>b</i>][1,3]benzothiazole
C15H9N3O2S
Acta Crystallographica Section E (2014) 70, 2 o143-o144
a=6.8068(3)Å b=21.0244(9)Å c=9.0699(4)Å
α=90.00° β=105.0770(10)° γ=90.00°
2-Bromo-1-[1-(4-bromophenyl)-5-methyl-1<i>H</i>-1,2,3-triazol-4-yl]ethanone
C11H9Br2N3O
Acta Crystallographica Section E (2014) 70, 7 o818
a=3.9699(10)Å b=19.437(5)Å c=15.402(4)Å
α=90.00° β=90.908(3)° γ=90.00°
3-Bromo-7-methoxy-2-phenylimidazo[2,1-<i>b</i>][1,3]benzothiazole
C16H11BrN2OS
Acta Crystallographica Section E (2013) 69, 4 o531
a=3.8346(4)Å b=9.4848(11)Å c=37.236(4)Å
α=90.00° β=91.810(2)° γ=90.00°
(<i>Z</i>)-<i>N</i>-[1-(Aziridin-1-yl)-2,2,2-trifluoroethylidene]-4-bromoaniline
C10H8BrF3N2
Acta Crystallographica Section E (2014) 70, 5 o550
a=11.642(2)Å b=8.5455(16)Å c=11.846(2)Å
α=90.00° β=116.106(3)° γ=90.00°
3-Bromo-2-[4-(methylsulfanyl)phenyl]-5,6,7,8-tetrahydro-1,3-benzothiazolo[3,2-<i>a</i>]imidazole
C16H15BrN2S2
Acta Crystallographica Section E (2014) 70, 5 o596-o597
a=7.3132(3)Å b=7.5663(3)Å c=14.4543(7)Å
α=95.0330(10)° β=97.1880(10)° γ=101.9380(10)°